To identify risk factors for the development of proliferative diabetic retinopathy, we compared 111 patients with longstanding insulin-dependent diabetes who had proliferative retinopathy (cases) with 81 patients with diabetes of similar duration (an average of 26 years) who did not have proliferative diabetic retinopathy (controls). The cases had diabetes that was more difficult to manage, as evidenced by their more frequent blood sugar levels above 200 mg per deciliter (11 mmol per liter) on routine clinic visits (odds ratio, 1.6 for each increment of 10 per cent in the relative frequency), and they expended less effort in managing their diabetes, as indicated by their less frequent testing of urine for sugar (odds ratio, 0.3). Among those who did not have myopia, the cases also had an excess of the HLA-DR phenotypes 4/0, 3/0, or X/X (odds ratio, 10.0). Among those with myopia, these phenotypes did not carry an increased risk of proliferative retinopathy. These results support a multifactorial model for the development of proliferative diabetic retinopathy; however, the mechanisms of action of the identified factors remain unknown.
This article has been cited by other articles:
Poulsen, L.
(2002). Blood pressure and cardiac autonomic function in relation to risk factors and treatment perspectives in Type 1 diabetes. Journal of Renin-Angiotensin-Aldosterone System
3: 222-242
[Abstract]
Giusti, C., Schiaffini, R., Brufani, C., Pantaleo, A., Vingolo, E. M., Gargiulo, P.
(2000). Coagulation pathways and diabetic retinopathy: abnormal modulation in a selected group of insulin dependent diabetic patients. Br J Ophthalmol
84: 591-595
[Abstract][Full Text]
Moy, C. S.
(1998). Case-Control Designs for Clinical Research in Ophthalmology. Arch Ophthalmol
116: 661-664
[Full Text]
Fulcher, T., Griffin, M., Crowley, S., Firth, R., Acheson, R., O'Meara, N.
(1998). Diabetic retinopathy in Down's syndrome. Br J Ophthalmol
82: 407-409
[Abstract][Full Text]
Logstrup, N., Sjolie, A. K., Kyvik, K. O., Green, A.
(1997). Long term influence of insulin dependent diabetes mellitus on refraction and its components: a population based twin study. Br J Ophthalmol
81: 343-349
[Abstract][Full Text]
Vitale, S., Maguire, M. G., Murphy, R. P., Hiner, C., Rourke, L., Sackett, C., Patz, A.
(1997). Interval Between Onset of Mild Nonproliferative and Proliferative Retinopathy in Type I Diabetes. Arch Ophthalmol
115: 194-198
[Abstract]
Malinowski, S. M., Pulido, J. S., Flickinger, R. R.
(1996). The Protective Effect of the Tilted Disc Syndrome in Diabetic Retinopathy. Arch Ophthalmol
114: 230-231
Harris, M. I.
(1996). Medical Care for Patients with Diabetes: Epidemiologic Aspects. ANN INTERN MED
124: 117-122
[Abstract][Full Text]
Arfken, C. L., Salicrup, A. E., Meuer, S. M., Priore, L. V. D., Klein, R., McGill, J. B., Rucker, C. S., White, N. H., Santiago, J. V.
(1994). Retinopathy in African Americans and Whites With Insulin-Dependent Diabetes Mellitus. Arch Intern Med
154: 2597-2602
[Abstract]
Raskin, P., Arauz-Pacheco, C.
(1992). The Treatment of Diabetic Retinopathy: A View for the Internist. ANN INTERN MED
117: 226-233
[Abstract]
Singer, D. E., Nathan, D. M., Fogel, H. A., Schachat, A. P.
(1992). Screening for Diabetic Retinopathy. ANN INTERN MED
116: 660-671
[Abstract]
Barzilay, J., Warram, J. H., Rand, L. I., Pfeifer, M. A., Krolewski, A. S.
(1992). Risk for Cardiovascular Autonomic Neuropathy Is Associated with the HLA-DR3/4 Phenotype in Type I Diabetes Mellitus. ANN INTERN MED
116: 544-549
[Abstract]
Hawkins, B. S.
(1988). Selection of Controls for Clinical Research Studies in Ophthalmology. Arch Ophthalmol
106: 835-840
[Abstract]
Seigel, D.
(1987). Designs for Clinical Research. Arch Ophthalmol
105: 1647-1649
[Abstract]
Previous
